These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. [Comparative studies on the reduction of lipids using clofibric acid and clofibrate in hyperlipoproteinemias]. Schwartzkopff W; Hoffmann H; Kästner W Med Welt; 1975 Dec; 26(51):2308-15. PubMed ID: 177837 [No Abstract] [Full Text] [Related]
16. [Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome]. Fabre J; Denizot M; Wildi E; Micheli H; Berthoud S Schweiz Rundsch Med Prax; 1973 Jun; 62(23):732-7. PubMed ID: 4705828 [No Abstract] [Full Text] [Related]
17. [Study of clofibrate. The opinion of Prof. D. Kritchevsky]. Fabbrocini V Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692 [No Abstract] [Full Text] [Related]
18. Clofibrate and the liver. Schwandt P; Klinge O; Immich H Lancet; 1978 Aug; 2(8084):325. PubMed ID: 79123 [No Abstract] [Full Text] [Related]